Clinical Trial Update: Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and tolerability of AMG 986 in healthy volunteers and heart failure patients; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• AMG 986

Snippet

Sponsor: Amgen | Conditions: Heart Failure, Healthy Volunteer | Phase 1 | Status: TERMINATED | Results posted: 2022-08-08